When GPX4 is inhibited by drugs, cancer cells lose the antioxidant enzymes that specifically scavenge lipid peroxides, resulting in excessive accumulation of lipid peroxides and ferroptosis; meanwhile, GPX4 inhibition also cause the inactivation of GSH, making cancer cells more vulnerable to oxidative damage [17]. This evidence concerns the gene GPX4 and cancer.